2024
Artificial intelligence applied to electrocardiographic images for scalable screening of cardiac amyloidosis
Sangha V, Oikonomou E, Krumholz H, Miller E, Khera R. Artificial intelligence applied to electrocardiographic images for scalable screening of cardiac amyloidosis. European Heart Journal 2024, 45: ehae666.3436. DOI: 10.1093/eurheartj/ehae666.3436.Peer-Reviewed Original ResearchATTR-CMBone scintigraphy scansTransthyretin amyloid cardiomyopathyPositive predictive valueAI-ECG algorithmCardiac amyloidosisScintigraphy scanAmyloid cardiomyopathyAI-ECGSex-matchedDevelopment cohortMyocardial remodelingUnder-diagnosedUnder-treatedMatched controlsPredictive valueUnder-recognizedTransthyretin stabilizersConvolutional neural networkPatientsECGArtificial intelligenceHospitalPrevalenceTransthyretinTRANSTHYRETIN AMYLOID CARDIOMYOPATHY IS ASSOCIATED WITH WORSE OUTCOMES WHEN COMPARED TO PATIENTS WITH NON-AMYLOID RELATED HEART FAILURE OF SIMILAR RACE AND ETHNICITY: THE SCAN-MP STUDY
Schmidt A, Ullah I, Teruya S, Fine D, Sabogal N, Foster R, Helmke S, Rodriguez C, Spencer B, Winburn M, Bampatsias D, Wardhere A, De Freitas C, Prokaeva T, Kattan C, Miller E, LaValley M, Maurer M, Ruberg F. TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IS ASSOCIATED WITH WORSE OUTCOMES WHEN COMPARED TO PATIENTS WITH NON-AMYLOID RELATED HEART FAILURE OF SIMILAR RACE AND ETHNICITY: THE SCAN-MP STUDY. Journal Of The American College Of Cardiology 2024, 83: 520. DOI: 10.1016/s0735-1097(24)02510-5.Peer-Reviewed Original Research
2020
Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy. Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/jaha.120.016038.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillator implantationCardioverter-defibrillator implantationNonischemic cardiomyopathyCardiac amyloidosisDiabetes mellitusCerebrovascular diseaseVentricular tachycardiaMultivariable Cox proportional hazards regression modelsCox proportional hazards regression modelProportional hazards regression modelsKaplan-Meier survival curvesCox proportional hazards modelPropensity-matched cohortOutcomes of patientsHazards regression modelsProportional hazards modelCause mortalityICD implantationRenal functionMultivariable analysisConclusions MortalityRisk factorsRegistry dataAmyloid cardiomyopathyHigh risk